Inequalities in pharmacologic treatment of spasticity in Sweden – health economic consequences of closing the treatment gap

BACKGROUND: The Swedish Healthcare Act states that patients should have equal access to healthcare. This study addresses at how this translates to pharmacological treatment of adult spasticity, including injections with botulinum toxin A (BoNT-A) and pumps for intrathecal baclofen (ITB). To address...

Descripción completa

Detalles Bibliográficos
Autores principales: Forsmark, Annabelle, Rosengren, Linda, Ertzgaard, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006187/
https://www.ncbi.nlm.nih.gov/pubmed/32030530
http://dx.doi.org/10.1186/s13561-020-0261-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006187/
https://www.ncbi.nlm.nih.gov/pubmed/32030530
http://dx.doi.org/10.1186/s13561-020-0261-7

Ejemplares similares